Vaccine trials among recipients of £20 million coronavirus research investment
Published on 25/03/2020
- Trials of new coronavirus vaccine among 6 projects to receive share of £20 million.
- Other projects to combat coronavirus include immediately repurposing existing treatments to treat patients already diagnosed with coronavirus.
- The UK is leading the scientific and medical response to the coronavirus outbreak
To read this article in full, please click here.